| Effect | None |
| Trial Design | Double blind |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 20 |
| Sex | Both Genders |
| Age Range | 65+ |
| Body Types | Overweight, Average |
300mg ALA supplementation for 4 weeks failed to significantly influence pathology and inflammation in a small sample of persons with rheumatoid arthritis.
